Search research articles
Contact Us
Filters
Showing results (531-540 of 563) with videos related to
Page
of 57
Sort By:
The Journal of Infectious Diseases
|
May 21, 2010
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
Ming-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C
Chun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2025
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study
Teng-Yu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 7, 2025
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C
Yen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, et al.
Hepatology Communications
|
October 29, 2024
Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus
Jee-Fu Huang, Tien-Jyun Chang, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology
|
February 5, 2025
Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study
Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
The American Journal of Gastroenterology
|
March 30, 2020
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Chung-Feng Huang, Hsueh-Chou Lai, Chi-Yi Chen, et al.
Hepatology International
|
August 8, 2021
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, et al.
American Journal of Cancer Research
|
August 15, 2022
Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study
Hung-Wei Wang, Pei-Chein Tsai, Chi-Yi Chen, et al.
Scientific Reports
|
March 28, 2020
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, et al.
Page
of 57
Search research articles
Search
Showing results (531-540 of 563) with videos related to
Sort By:
Page
of 57
The Journal of Infectious Diseases
|
May 21, 2010
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
Ming-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C
Chun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 22, 2025
Survival impact of hepatitis C virus eradication in patients with or without active hepatocellular carcinoma: A nationwide cohort study
Teng-Yu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
February 7, 2025
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C
Yen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, et al.
Hepatology Communications
|
October 29, 2024
Clinical care guidance in patients with diabetes and metabolic dysfunction-associated steatotic liver disease: A joint consensus
Jee-Fu Huang, Tien-Jyun Chang, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology
|
February 5, 2025
Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study
Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
The American Journal of Gastroenterology
|
March 30, 2020
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Chung-Feng Huang, Hsueh-Chou Lai, Chi-Yi Chen, et al.
Hepatology International
|
August 8, 2021
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, et al.
American Journal of Cancer Research
|
August 15, 2022
Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study
Hung-Wei Wang, Pei-Chein Tsai, Chi-Yi Chen, et al.
Scientific Reports
|
March 28, 2020
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, et al.
Page
of 57